Tsuneo Kobayashi is an Oncologist and completed his medical degree at Tottori University. He then entered the graduate school of medicine at Kyoto University, doing research in biochemistry and received his PhD. His career has been iconic in the field of alternative cancer care. His achievements are too numerous to list. Dr. Kobayashi serves on the Advisory Board for EuroMed.
Tsuneo Kobayashi
M.D.
Medical Maverick Tsuneo Kobayashi
Originally published at www.japaninc.com December 2005
Melding East and West: a forerunner of cancer treatment and prevention
by John Dodd
Your doctor examines the test results, gives you a serious look, and says, “You may have cancer.” Perhaps no other words strike greater fear in a patient. Suddenly all your daily worries and professional and personal goals pale with the realization you may be dead within a year.
Of course, not all cancer is fatal, but with cancer accounting for 23 percent of deaths in the United States (Source: CDC 2002) and for over 30 percent in Japan (Source: Facts and Figures of Japan 2005), any diagnosis of cancer makes the patient reassess their values. In the days after diagnosis, we are conditioned to turn to conventional medical treatment for help. Japan is no different.
With an array of technology and compounds being tested around the world, we trust our doctors to give it their best shot to kill the tumor and have us resume a normal life in a few months. In particular, we are conditioned to accept that we do in fact only have “one shot” and if we dally with other forms of treatment, not only will we not get better, but the delay will seal our death warrant.
So the one-chance indoctrination, and the urge to comply, ever so strong in Japanese society, creates a situation where the overwhelming majority of cancer research focuses on improving treatments that have been around for almost a hundred years: radiation, chemotherapies, and surgery — all of which can be considered “decisive” means of rooting out the cancer. As forms of recurrence treatment, almost all of these therapies have failed. 99 percent of treatments focus on early cancer, and 70 percent of treatments for advanced cancers prolong patients’ lives for only a short time.
The establishment gives little credence to “alternative” therapies — virtually all of which are viewed as irresponsible and without efficacy. At the bottom of the pile of such alternatives are holistic therapies that bring diet and lifestyle into the mix.